CSIMarket
 
Surmodics Inc  (SRDX)
Other Ticker:  
 
 
Price: $27.4700 $-0.70 -2.485%
Day's High: $28.2688 Week Perf: -6.44 %
Day's Low: $ 27.29 30 Day Perf: -15.63 %
Volume (M): 43 52 Wk High: $ 39.41
Volume (M$): $ 1,176 52 Wk Avg: $30.02
Open: $28.07 52 Wk Low: $16.00



 Market Capitalization (Millions $) 384
 Shares Outstanding (Millions) 14
 Employees 316
 Revenues (TTM) (Millions $) 134
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) 21
 Capital Exp. (TTM) (Millions $) 3

Surmodics Inc
Surmodics Inc is a medical technology company that designs, manufactures, and markets a range of products focused on enhancing the performance of medical devices. Founded in 1979 and headquartered in Eden Prairie, Minnesota, the company has its presence in more than 80 countries worldwide. Surmodics works closely with its customers and partners to develop innovative solutions to address the critical needs in the medical community.

The company's product portfolio includes surface modification coatings, drug delivery coatings, hydrophilic coatings, antimicrobial coatings, and other related technologies. These coatings are designed to improve the performance of medical devices, such as catheters, stents, drug-eluting balloons, and diagnostic systems. Surmodics' products are used in a wide range of medical specialties, including cardiology, ophthalmology, and neurology.

Surmodics operates through two business segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment involves developing, manufacturing, and selling medical device technologies, while the IVD segment involves developing, manufacturing, and selling diagnostic tests and equipment. While the Medical Device segment constitutes the majority of the company's revenue, the IVD segment offers healthy growth opportunities for the future.

Surmodics is known for its research and development capabilities, and the company invests heavily in R&D to develop new products and technologies. The company has a dedicated team of scientists and engineers who work on new ideas and projects that can be commercialized into innovative, market-leading products. The company also collaborates with leading medical device companies and academic institutions to advance its research and development capabilities.

One of Surmodics' key strengths lies in its ability to provide customized solutions to customers. The company offers co-development services, where it collaborates with customers to design and develop products that meet their specific needs. Additionally, Surmodics' experienced sales and marketing team works closely with customers to identify new market opportunities and develop customized marketing strategies.

The company's financials are strong, with steady revenue growth and profitability. The company generates the majority of its revenue from the United States, but it has a growing international presence. Surmodics' conservative balance sheet and low debt make it well-positioned to invest in new products and opportunities.

In conclusion, Surmodics Inc is a medical technology company that specializes in developing, manufacturing, and selling products that enhance the performance of medical devices. With a strong focus on R&D, market-leading products, and customer collaboration, Surmodics is well positioned to continue its growth and success in the medical technology industry.


   Company Address: 9924 West 74th Street Eden Prairie 55344 MN
   Company Phone Number: 500-7000   Stock Exchange / Ticker: NASDAQ SRDX
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

Surmodics Shines at VEITH Symposium: Positive Trial Data and Steady Growth Chart the Path to Success

Published Thu, Nov 16 2023 12:30 PM UTC



Surmodics, a renowned provider of medical device and in vitro diagnostic technologies, recently presented the noteworthy 24-month data from the SWING Trial at the prestigious 50th annual VEITH Symposium in New York. The trial evaluated the safety and performance of the Sundance Sirolimus Drug-Coated Balloon (DCB), marking an important milestone in the healthcare in...

Product Service News

Surmodics Announces Positive 24-Month Data from SWING Trial and Sets Path for Revolutionary Medical Advancements

Published Tue, Nov 7 2023 12:30 PM UTC

Surmodics Announces Positive 24-Month Data from SWING Trial at VEITH Symposium
Surmodics, Inc., a prominent provider of medical device and in-vitro diagnostic technologies, has recently revealed exciting news regarding their Sundance Sirolimus Drug-Coated Balloon (DCB). The company announced that Professor Ramon Varcoe will present the 24-month data from the SWING Trial...

Stock Transactions

Preside by Surmodics: The Game-Changing Medical Device Coating Transforming Neurovascular Procedures

Published Tue, Oct 31 2023 11:30 AM UTC

Surmodics Revolutionizes Medical Device Coating Technology with Preside, Enhancing Neurovascular Procedures
EDEN PRAIRIE, Minn. - Surmodics, Inc. (NASDAQ: SRDX), the renowned pioneer in medical device coating technologies, has made yet another groundbreaking advancement in the field with the commercial launch of its cutting-edge hydrophilic medical device coating technol...






 

Surmodics Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com